Clinical trialObservationalUnknown
Quality of Life of Pancreatic Cancer Patients:Psychometric Validation of Chinese Version in Taiwan
Quality of Life of Pancreatic Cancer Patients:Psychometric Validation of Chinese Version of the EORTC QLQ-PAN26 and EORTC QLQ-C30 in Taiwan
- Outcome
- Outcome unknown
- Phase
- Observational
- Status
- Unknown
- Study type
- Observational
- Start
- 22 November 2021
- Listed end
- 22 November 2024
- Enrollment
- 300 participants
- Sites
- 1
- Primary outcomes
- Quality of Life (EORTC QLQ-C30 ); Quality of Life (EORTC QLQ-PAN26 ); Quality of Life (EORTC QLQ-PAN26 ); Quality of Life(SF-36)
- Sponsor type
- Other government
- Results posted
- No
- Last update
- 14 November 2023
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
This study will investigate the reliability and validity of Chinese version of the quality of life scale in EORTC QLQ-PAN26 and EORTC QLQ-C30 on pancreatic cancer patients in Taiwan
Detailed description public domain (ClinicalTrials.gov)
1. Verify the reliability and validity of Chinese version of the EORTC QLQ-C30 Quality of Life Scale and the chinese version of the EORTC QLQ-PAN26 Quality of Life Scale. 2. Verify the construct validity of the Chinese version of the EORTC QLQ-PAN26 Quality of Life Scale, perform factor analysis, test-retest reliability, and known group validity 3. Verify the criterion related validity of Chinese version of the EORTC QLQ-C30 Quality of Life Scale and the SF-36 Quality of Life Scale